A newborn’s first encounter with harmful chemicals may occur before their first breath, according to a major global assessment released 17 November by the UN Environment Programme (UNEP) and the World Health Organization (WHO). The report, The State of the Science on Endocrine-Disrupting Chemicals 2026, is the first comprehensive review in over a decade, and it delivers its central warning sharply: exposure to hormone-disrupting chemicals begins before birth and can impact health across generations.
Endocrine-disrupting chemicals (EDCs)—a broad group including substances found in plastics, personal care products, pesticides, and industrial materials—have now been detected in human blood, breast milk and, crucially, cord blood. This reveals that even fetuses are directly exposed. Early-life encounters with these chemicals are linked to disruptions in brain development, growth, reproductive health, and metabolic and immune functions. Some effects, say health officials, may be irreversible.
More than 350,000 chemicals and mixtures are registered for commercial use worldwide, yet only a fraction have been evaluated for endocrine-disrupting properties, the agencies found. Many EDCs—such as bisphenol A, phthalates and polychlorinated biphenyls—continue to circulate widely despite partial regulation or legacy bans, leaving gaps across supply chains and environments. “Many exposures to these chemicals happen through everyday products,” UNEP Industry and Economy Director Sheila Aggarwal Khan explained in the report, urging companies to proactively replace hazardous compounds before regulation catches up.
Human health is only part of the toll. The assessment documents mounting evidence that EDCs negatively impact reproduction, development, and behavior in fish, birds, amphibians, and mammals. The breadth of damage underscores a disturbing fact: EDCs disrupt essential hormones that regulate core bodily processes in both people and wildlife. What’s more, the science is only just catching up to the complexity of real-world exposures, since most people—and ecosystems—face a mix of different chemicals, not just isolated compounds. But regulatory regimes, the agencies note, often focus on one chemical at a time.
The financial implications of EDC exposure are also daunting. WHO and UNEP warn that diseases tied to these chemicals may cost at least one percent of global GDP—potentially hundreds of billions of dollars each year. Despite this, the report was blunt about the sluggish pace of evaluation and policy measures: substantial uncertainties persist, but the evidence for harm is now strong enough to justify preventive action without waiting for complete certainty.
To guide policy, UNEP released a companion synthesis, From Evidence to Action, aiming to help governments and industry prioritize interventions across sectors ranging from food packaging and toys to cosmetics, agriculture, and healthcare. The recommendations were launched during the inaugural International Conference of the Global Framework on Chemicals in Geneva, where participants debated how to accelerate a transition towards a planet and populace free of chemical harm.
The underlying message from both UNEP and WHO officials is clear: protecting current and future generations hinges on early risk identification, stronger chemical monitoring, and sector-wide shifts toward safer alternatives—particularly in products for pregnant women, children, and those most vulnerable to hormonal disruption. EDCs may be woven into the fabric of daily life, but their dangers are neither invisible nor inevitable.
The report also highlights the challenge ahead: although some adverse effects associated with certain EDCs have been reversed following regulatory action, the overwhelming majority of chemicals in use remain untested for such properties. This leaves policymakers, businesses, and consumers grappling with a key question: if only a fraction of the chemicals that shape modern environments have been examined for endocrine activity, how can health protections be truly effective?